Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 8.842E-07 | 1.750E-03 | CA2, CA7 |
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 2.103E-06 | 3.053E-03 | CA1, CA12, CA2, CA4, CA7, CA9 |
CC | GO:0016020; membrane | GO:0016323; basolateral plasma membrane | 2.606E-06 | 3.546E-03 | CA2, CA4, CA9, TSHR |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 4.417E-06 | 5.343E-03 | CYP1A2, CYP2C19 |
MF | GO:0003824; catalytic activity | GO:0004064; arylesterase activity | 4.417E-06 | 5.343E-03 | CA1, CA2 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 1.066E-20 | 2.322E-16 | CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 6.317E-17 | 6.878E-13 | CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 1.240E-14 | 5.401E-11 | CA1, CA12, CA2, CA4, CA7, CA9 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00910 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.525E-20 | 6.566E-19 | CA12; CA1; CA2; CA4; CA7; CA9; CA14 |
hsa04964 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 6.914E-05 | 8.988E-04 | CA2; CA4 |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.108E-04 | 9.599E-04 | CYP1A2; CYP2C19 |
hsa00982 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 6.323E-04 | 4.110E-03 | CYP1A2; CYP2C19 |
hsa05204 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 8.917E-04 | 4.637E-03 | CYP1A2; CYP2C19 |
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.747E-03 | 1.190E-02 | CYP1A2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | CA2; CA4 |
H00-H59: Diseases of the eye and adnexa | Ocular hypertension | H40.0 | CA4; CA4 |
NA: NA | Edema | NA | CA2 |
H00-H59: Diseases of the eye and adnexa | Chronic glaucoma | H40-H42 | CA1 |
C00-D49: Neoplasms | Thyroid cancer diagnosis | C73 | TSHR |
C00-D49: Neoplasms | Renal cancer | C64 | CA9 |
C00-D49: Neoplasms | Solid tumours | C00-D48 | CA9 |
I00-I99: Diseases of the circulatory system | High blood pressure | I10-I16 | CA2 |
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9 |
C00-D49: Neoplasms | Breast cancer | C50 | CA9 |
H00-H59: Diseases of the eye and adnexa | Glaucoma | H40-H42 | CA1; CA1 |
W85-W99: Exposure to electric current, radiation and extreme ambient air temperature and pressure | Diagnostic test to differentiate primary and secondary hypothyroidism | W88 | TSHR |
C00-D49: Neoplasms | Cancer | C00-C96 | CA1; CA9 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CA2 |
I00-I99: Diseases of the circulatory system | Edema associated with congestive heart failure | I50, R60.9 | CA2 |
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9 |
K00-K95: Diseases of the digestive system | Duodenal ulcers | K25-K27 | CA2; CA1 |
C00-D49: Neoplasms | Thyroid cancer | C73 | TSHR |